Position in ABBV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$109,360,931
+$17,734,157 QoQ
Shares Held
502,832
+25.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026THORNBURG INVESTMENT MANAGEMENT INC holds $1,242,934,030 across 7 Drug Manufacturers - General names. ABBV ranks #3 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,858,651 | $563,783,150 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,728,673 | $448,522,075 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
502,832 | $109,360,931 | |
| 4 | PFE |
Pfizer Inc
|
2,242,186 | $62,960,582 | |
| 5 | LLY |
ELI LILLY & Co
|
60,178 | $55,349,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
38,400 | $2,328,960 | |
| 7 | NVS |
Novartis AG
|
4,114 | $628,413 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $109,360,931 | 502,832 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $91,626,774 | 401,010 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $93,023,510 | 401,760 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $59,423,458 | 320,135 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $68,060,686 | 324,841 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $144,310,170 | 812,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $160,427,815 | 812,375 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $138,519,208 | 807,598 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $147,063,595 | 807,598 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $155,699,133 | 1,004,705 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $149,761,327 | 1,004,705 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $135,363,904 | 1,004,705 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $159,801,095 | 1,002,705 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $174,471,570 | 1,079,584 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $186,115,314 | 1,386,747 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $402,818,151 | 2,630,048 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $446,241,331 | 2,752,707 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $470,816,400 | 3,477,226 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $381,852,356 | 3,539,931 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $385,633,177 | 3,423,590 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $373,874,992 | 3,454,768 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $369,975,984 | 3,452,879 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $324,807,194 | 3,708,268 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $366,791,152 | 3,735,905 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $262,551,425 | 3,446,009 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||